Stock IMVT IMMUNOVANT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Immunovant, Inc.

Equities

IMVT

US45258J1025

Real-time Estimate Cboe BZX
Other stock markets
 09:46:58 2024-04-19 am EDT 		5-day change 1st Jan Change
28.22 USD -0.35% Intraday chart for Immunovant, Inc. -3.68% -32.90%
Mar. 28 Oppenheimer Initiates Coverage on Immunovant With Outperform Rating, $50 Price Target MT
Mar. 13 Goldman Sachs Starts Coverage on Immunovant With Buy Rating, $50 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. IMVT Stock
  4. Revisions Immunovant, Inc.